Weill Cornell awarded $17.4M grant to develop shorter TB treatment regimen

The researchers aim to shift TB drug development toward creating new drugs from the start to work in the combinations needed to cure tuberculosis.

Uncovering hidden complexity in a key drug target for brain disorders

Metabotropic glutamate receptors interact in varied ways with their principal regulatory proteins, according to Weill Cornell Medicine investigators. The findings could inform treatments for epilepsy, depression and anxiety disorders.

Stress hormone timing creates a different kind of obesity

Obesity caused by disrupted stress-hormone rhythms is metabolically very different from obesity caused by a high-fat diet, according to new research.

Hops and dreams: Cornell helps new varieties go from field to glass 

The Cornell Hop Breeding Program aims to give New York growers and brewers cultivars suited to the state's climate and disease pressure.  

Cornellians to address AI, NY energy future at Climate Week NYC

Cornell and global leaders will come together at Climate Week NYC Sept. 20-27 to discuss some of the world’s most pressing sustainability challenges, including harnessing AI’s power while mitigating its negative impacts.

Antifungal therapy restores gut microbiome in IBD patients

A commonly used systemic antifungal medication may help reduce symptoms in a subset of patients with inflammatory bowel disease.

Model helps scientists build better protein-degrading therapies

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer. 

Tuberculosis transmission may hold key to prevention

Tuberculosis bacteria released into the air from infected individuals dry out to form infectious particles that are second only to measles in contagiousness, Weill Cornell Medicine investigators have found.

Campaign closes with record support for students and research

Cornell’s To Do the Greatest Good campaign surpassed its goal of raising more than $5 billion and engaging more than 200,000 alumni – achievements that will enhance opportunities for students and accelerate critical faculty research.